Statera Biopharma, Inc. (STAB) Financials
Stock symbol STAB is outdated, potentially delisted? Maybe it is available on other exchange?
STAB Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2022 | 21.2 million | 22.7 million |
| June 30, 2022 | 13.5 million | 20.5 million |
| March 31, 2022 | 13.5 million | 15.9 million |
| Dec. 31, 2021 | 21.2 million | 22.7 million |
STAB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2022 | -8.2 million | 1.1 million |
| June 30, 2022 | -168511 | -1.1 million |
| March 31, 2022 | -3.8 million | 452537 |
| Dec. 31, 2021 | -8.2 million | 1.1 million |
STAB Net Income
No data available :(
STAB Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2022 | 2.0 million | - | 1.0 million |
| June 30, 2022 | - | - | 1.2 million |
| March 31, 2022 | - | - | 1.2 million |
| Dec. 31, 2021 | - | - | 1.1 million |
STAB Shares Outstanding
STAB Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2022 | 96913 | 5.6 million | 4.6 million | 53402 |
| June 30, 2022 | - | 973604 | 2.3 million | - |
| March 31, 2022 | 6454 | 3.2 million | 3.8 million | - |
| Dec. 31, 2021 | 6454 | 5.6 million | 4.9 million | - |
STAB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2022 | 1.3 million | 372387 |
| June 30, 2022 | - | 200936 |
| March 31, 2022 | - | 353671 |
| Dec. 31, 2021 | - | 372387 |
STAB
Price: $0
52 week price:
Earnings Per Share: -2.36 USD
Exchange: OEM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 370699
Market Capitalization: 42850